Search research articles
Contact Us
Filters
Showing results (181-190 of 189) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 189 results.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 16, 2016
Differential miRNA expression in pleural effusions derived from extracellular vesicles of patients with lung cancer, pulmonary tuberculosis, or pneumonia
Jin Lin, Yan Wang, Ye-Qing Zou, et al.
Journal of Clinical Laboratory Analysis
|
April 7, 2017
Differential expression of urinary exosomal microRNAs in IgA nephropathy
Qing-Hua Min, Xi-Min Chen, Ye-Qing Zou, et al.
Cancer Science
|
October 13, 2020
Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma
Dingwei Ye, Jiyan Liu, Aiping Zhou, et al.
Medicine
|
November 3, 2017
Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions
Yan Wang, Yan-Mei Xu, Ye-Qing Zou, et al.
Signal Transduction and Targeted Therapy
|
December 17, 2024
Patient-reported outcomes of rezvilutamide versus bicalutamide in combination with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer patients (CHART): a randomized, phase 3 study
Hongkai Wang, Shusuan Jiang, Hong Luo, et al.
The Lancet. Oncology
|
September 8, 2022
Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial
Weijie Gu, Weiqing Han, Hong Luo, et al.
Asia-Pacific Journal of Clinical Oncology
|
October 14, 2020
Radium-223 in Asian patients with castration-resistant prostate cancer with symptomatic bone metastases: A single-arm phase 3 study
Tie Zhou, Fangjian Zhou, Jianming Guo, et al.
Scientific Reports
|
February 3, 2016
The influence of genetic variants of sorafenib on clinical outcomes and toxic effects in patients with advanced renal cell carcinoma
Chao Qin, Qiang Cao, Pu Li, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2022
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
Xinan Sheng, Dingwei Ye, Aiping Zhou, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 189) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 189 results.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 16, 2016
Differential miRNA expression in pleural effusions derived from extracellular vesicles of patients with lung cancer, pulmonary tuberculosis, or pneumonia
Jin Lin, Yan Wang, Ye-Qing Zou, et al.
Journal of Clinical Laboratory Analysis
|
April 7, 2017
Differential expression of urinary exosomal microRNAs in IgA nephropathy
Qing-Hua Min, Xi-Min Chen, Ye-Qing Zou, et al.
Cancer Science
|
October 13, 2020
Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma
Dingwei Ye, Jiyan Liu, Aiping Zhou, et al.
Medicine
|
November 3, 2017
Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions
Yan Wang, Yan-Mei Xu, Ye-Qing Zou, et al.
Signal Transduction and Targeted Therapy
|
December 17, 2024
Patient-reported outcomes of rezvilutamide versus bicalutamide in combination with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer patients (CHART): a randomized, phase 3 study
Hongkai Wang, Shusuan Jiang, Hong Luo, et al.
The Lancet. Oncology
|
September 8, 2022
Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial
Weijie Gu, Weiqing Han, Hong Luo, et al.
Asia-Pacific Journal of Clinical Oncology
|
October 14, 2020
Radium-223 in Asian patients with castration-resistant prostate cancer with symptomatic bone metastases: A single-arm phase 3 study
Tie Zhou, Fangjian Zhou, Jianming Guo, et al.
Scientific Reports
|
February 3, 2016
The influence of genetic variants of sorafenib on clinical outcomes and toxic effects in patients with advanced renal cell carcinoma
Chao Qin, Qiang Cao, Pu Li, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2022
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
Xinan Sheng, Dingwei Ye, Aiping Zhou, et al.
Page
of 19